taVNS plus dexmedetomidine to reduce postoperative nausea and vomiting after laparoscopic surgery
Official title: The Effect of Dexmedetomidine Combined With Percutaneous Auricular Vagus Nerve Stimulation on Postoperative Nausea and Vomiting in Female Laparoscopic Patients: A Randomized Controlled Trial
Run by Affiliated Hospital of Nantong University · NCT07271147 · Data updated 2026-11-12
We will see if adding noninvasive ear (taVNS) stimulation to the sedative dexmedetomidine reduces postoperative nausea and vomiting in women having elective laparoscopic surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | Women only |
| Enrollment | 176 (estimated) |
| Sponsor | Affiliated Hospital of Nantong University Academic / other |
| Locations | 1 site (Nantong, Jiangsu) |
| Status | Recruiting |
| Started | December 7, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT07271147 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women (18–65 years) with ASA physical status I–II who are scheduled for elective laparoscopic surgery under general anesthesia and can provide informed consent are the ideal candidates.
✕Probably not a fit
Patients with ASA ≥ III, significant cardiovascular or liver/kidney dysfunction, obesity (BMI >30), pregnancy or breastfeeding, implanted stimulators, recent use of antiemetics/opioids/psychoactive drugs, or other listed exclusions are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Women aged 18–65 scheduled for elective laparoscopic surgery are recruited a week before surgery, consented, and randomized 1:1 to receive either real transcutaneous auricular vagus nerve stimulation (taVNS) or a sham procedure in addition to dexmedetomidine. The taVNS intervention starts 30 minutes before anesthesia induction and continues until the end of surgery, stopping after extubation in the PACU, with the intervention and postoperative follow-up performed by different blinded researchers. The trial collects postoperative nausea and vomiting incidence and related clinical measures and will explore physiological markers to suggest possible mechanisms for any observed effect. Randomization is double-blind to participants and the researchers who perform follow-up assessments.
Why it matters
Potential benefit: If successful, the approach could lower the rate and severity of postoperative nausea and vomiting, improving patient comfort and reducing the need for rescue antiemetics.
How similar studies have gone: Dexmedetomidine has shown some benefit for reducing PONV in prior trials and taVNS has limited early evidence for antiemetic effects, but combining taVNS with dexmedetomidine is a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged 18 to 65; * Elective laparoscopic surgery under general anesthesia; * Classified as American Society of Anesthesiologists (ASA) physical status I to II; * Capable of understanding the study procedures and various assessment scales and able to effectively communicate with the researchers; * Willing to participate in the study and provide written informed consent. Exclusion Criteria: * Patients with ASA anesthesia classification ≥ III; * Poorly controlled hypertension, atrioventricular block ≥ second degree, obesity (BMI \> 30 kg/m²); * Pregnant or breastfeeding; * Known allergy to drugs used in the study protocol, history of traumatic brain injury, history of gastrointestinal surgery; * Liver or kidney dysfunction (liver enzymes or creatinine ≥ 1.5 times the normal value), alcoholism or drug abuse, mental illness, use of antiemetics, opioids, psychoactive drugs, or corticosteroids within 24 hours before surgery; * Patients with implanted stimulators (such as pacemakers, implantable vagus nerve stimulators, deep brain stimulators, spinal cord stimulators, etc.), cochlear implants, or metal implants (except in dental cases); * Skin lesions or dermatological diseases at the site of electrical stimulation; * Preoperative heart rate \< 50 bpm or the presence of sinoatrial node disease or second-degree or higher atrioventricular block; * Patients unable to cooperate with assessments; * Patients participating in other clinical trials.
Where it's running
-
Affiliated hospital of Nantong University
Nantong, Jiangsu, China Recruiting
Study contacts
- Principal investigator: Chao-Chao Zhong — Affiliated Hospital of Nantong University
- Study coordinator: Chao-Chao Zhong, M.D.;P.h.D
- Email: zhong249767626@163.com
- Phone: 15152460489
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See how nasal ondansetron compares to IV in healthy adults
This study tests whether a nasal spray form of ondansetron delivers similar blood levels as the IV version in healthy adults.
-
Postoperative nausea, vomiting and pain after bariatric surgery in Sweden
This study looks at how often people have nausea, vomiting, and pain after bariatric surgery in Sweden and whether anesthesia type or regional blocks affect those outcomes.
-
Time to first rescue antiemetic after two dual-drug regimens for PONV in gallbladder surgery
This trial tests whether ondansetron plus metoclopramide delays the need for rescue antiemetic more than dexamethasone plus metoclopramide in adults at moderate-to-high risk undergoing laparoscopic cholecystectomy.
-
Comfort Tote to help recovery after scoliosis surgery in teens
This study tests whether a therapeutic Comfort Tote can reduce pain and anxiety after surgery for adolescent idiopathic scoliosis.
-
Menstrual cycle effects on optic nerve sheath diameter during laparoscopic gynecologic surgery
This study will try to see if menstrual cycle phase changes the optic nerve sheath size and affects postoperative nausea, vomiting, and thinking in women having elective laparoscopic gynecologic surgery.
-
High- vs low-dose propofol to reduce nausea after coronary bypass
We will see if giving higher-dose propofol during coronary artery bypass surgery reduces postoperative nausea and vomiting in adults having elective CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.